In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd
In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd

In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd

We anticipate stronger growth through our upcoming product launches in domestic and export markets, improved operational efficiency, and the introduction of higher-margin products, articulates Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd.

Siddharth Mane Article rating: 4.0

We anticipate stronger growth through our upcoming product launches in domestic and export markets, improved operational efficiency, and the introduction of higher-margin products, articulates Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd.

 

DSIJ MINDSHARE

Mkt Commentary17-May, 2024

Bonus and Spilt Shares17-May, 2024

Bonus and Spilt Shares17-May, 2024

Swing Trading17-May, 2024

Multibaggers17-May, 2024

Knowledge

[EasyDNNnews:Categories separator="" last]15-May, 2024

[EasyDNNnews:Categories separator="" last]14-May, 2024

[EasyDNNnews:Categories separator="" last]14-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR